ARCHIVES

Neratinib Graduates from I-SPY Phase II Adaptive Trial Regimen

This article is from The Cancer Letter archive.

Vol. 37 No. 4 | April 25, 2014

Download PDF Visit The Full Archive

Related Articles

NIH Human Connectome Project To Map Brain Connections

July 31, 2009

DCE Reorganization Planned To Stem Departures, Stabilize

March 24, 1995

In Brief: Wyngaarden Suspends NIH Funds for Pennsylvania Head Injury Center Over Animal Care Problems

July 26, 1985

ASCO And ESMO Publish Training Recommendations

November 26, 2004

Longterm Followup Finds Taxotere Improves Survival

January 25, 2008

President’s FY 1992 Budget Seeks $1.81 Billion For NCI, 5.6% Increase, But $800M Below Byspass

February 8, 1991